OMICS AND PROGNSTIC MARKERS

0 OM-003. MOLECULAR FEATURES OF ADULT PATIENTS WITH GANGLIOGLIOMAS Shlomit Yust-Katz , Mark Anderson, Adriana Olar, Agda Eterovic, Nader Ezzeddine, Ken Chen, Hao Zhao, Gregory Fuller, Kenneth Aldape , and John de Groot; The UT MD Anderson Cancer Center , Houston, TX , USA 1 Ludwig Maximilians Universit a t M u nchen , M u nchen , Germany 2 OM-002. MOLECULAR CHARACTERIZATION OF 11p-DELETED DIFFUSE LOW-GRADE GLIOMAS Agusti Alentorn 3 Helmholtz Zentrum M u nchen , Neuherberg , Germany 4 Department of Neurological Surgery, University of California, San Francisco , San Francisco, CA , USA 5 OM-001. CONSIDERATION OF RELATIONSHIPS BETWEEN GENETIC ABNORMALITY AND CLINICAL PICTURE INGLIOMA WITHOUT 1 7 AND 2 1p/19q Kazuhide Adachi 6 Cardiovascular Research Institute, UCSF , San Francisco, CA , USA 7 Institute of Human Genetics, UCSF , San Francisco, CA , USA 8 Brain Tumor Research Center, UCSF , San Francisco, CA , USA 9 Helen Diller Family Comprehensive Cancer Center, UCSF , San Francisco, CA , USA 10 OM-004. CLONAL EXPANSIONS AND EVOLVING SUBPOPULATIONS IN GLIOBLASTOMA MULTIFORME Noemi Andor 11 Jawaharlal Nehru Centre for Advanced Scientific Research , Bangalore , India 12 Indian Institute of Science , Bangalore , India 13 National Institute of Mental Health and Neurosciences , Bangalore , India 14 OM-005. NOVEL GENES AND GENE SIGNATURE IN PROGNOSTICATION OF GLIOBLASTOMA: POTENTIAL TARGETS AND PATHWAY IDENTIFICATION Arimappamagan Arivazhagan 15 Sri SatyaSai Institute of Higher Medical Sciences , Bangalore , India 16 Acibadem University School of Medicine , Istanbul , Turkey 17 OM-014. GENOMIC ANALYSIS OF TRAF7-ONLY MUTANT MENINGIOMAS REVEALS NOVEL DRIVER MUTATIONS Victoria Clark 18 Memorial Sloan-Kettering Cancer Center , New York, NY , USA 19 Yale University School of Medicine , New Haven, CT , USA 20 OM-010. LOSS OF CIC AND FUBP1 EXPRESSIONS ARE POTENTIAL MARKERS OF SHORTER TIME TO RECURRENCE IN OLIGODENDROGLIAL TUMORS Aden Ka-Yin Chan 21 University Hospital of Bonn , Bonn , Germany 22 University Hospital of Cologne , Cologne , Germany 23 Bahcesehir University School of Medicine , Istanbul , Turkey 24 OM-030. EXPRESSION AND PROGNOSTIC SIGNIFICANCE OF CYSTEINE-RICH PROTEIN 61 IN GLIOBLASTOMA Joji Ishida , Kazuhiko Kurozumi, Tomotsugu Ichikawa, Manabu Onishi, Kentaro Fujii, Yosuke Shimazu, Tetsuo Oka , and Isao Date; Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan 25 Department of Biostatistics, University of West of England , Bristol , UK 26 OM-029. MGMT PROMOTER METHYLATION IS PRESENT IN LOW GRADE GLIOMA (WHO GRADE II/III) AND GLIOBLASTOMA MULTIFORME IN THE ABSENCE OF IDH MUTATIONS Harry R Haynes 27 Bristol Genetics Laboratory, Southmead Hospital , North Bristol NHS Trust, Bristol , UK 28 Department of Neuropathology and Brain Tumour Research Group, Frenchay Hospital , North Bristol NHS Trust, Bristol , UK 29 OM-028. EGFR AND EGFRvIII EXPRESSION IN GLIOBLASTOMA Claire Faulkner 30 Neuro-oncology Department, Bristol Haematology and Oncology Centre , Bristol , UK 31 OM-038. IDENTIFICATION OF CANDIDATE GENES ASSOCIATED WITH MALIGNANT TRANSFORMATION OF IDH-MUTATED LOW-GRADE ASTROCYTOMAS USING GENOME-WIDE COPY NUMBER VARIATION ANALYSIS Tareq A Juratli 32 The Ohio State University , Arthur G. James Comprehensive Cancer Center and Richard L. Solove Research Institute, Department of Radiation Oncology , Columbus, OH , USA 33 OM-036. RECEPTOR/RAS/PI3K/Akt/mTOR VARIATIONS IN Akt PATHWAY SUBTYPES SUGGEST THERAPEUTIC ALTERNATIVES Anna Joy 34 Technical University Dresden, University Hospital Dresden, Department of Neuropathology , Dresden , Germany 35 Technical University Dresden, University Hospital Dresden, Department of Neurosurgery , Dresden , Germany 36 OM-035. THE MEDULLOBLASTOMA METHYLOME REVEALS NEW EPIGENETIC REGULATORY MECHANISMS David T. W. Jones 37 University of Arizona College of Medicine - Phoenix , Phoenix, AZ , USA 38 The Translational Genomics Research Institute , Phoenix, AZ , USA 39 The Ohio State University, Center of Biostatistics , Columbus, OH , USA 40 OM-042. PROGNOSTIC VALUES OF LONG NON-CODING RNA SIGNATURES IN GLIOBLASTOMA MULTIFORME Xiao-qin Zhang 41 OM-041. GENOME-WIDE CNV ANALYSIS IDENTIFIES LOCI PUTATIVELY ASSOCIATED WITH DELAYED TIME TO FIRST RECURRENCE IN IDH-MUTANT LOW-GRADE ASTROCYTOMAS Tim Lautenschlaeger 42 Department of Statistics and Actuarial Science, Faculty of Science, The University of Hong Kong , Hong Kong , Hong Kong 43 Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital , Hong Kong , Hong Kong 44 OM-039. IDH1 STATUS AS A DIAGNOSTIC AND PROGNOSTIC MARKER FOR MALIGNANT ASTROCYTOMAS WITH LIMITED HISTOLOGICAL SPECIMEN: THE ROLE OF SURGICAL RESECTION, PATHOLOGICAL ANALYSIS AND MOLECULAR TESTING Betty YS Kim 45 Harvard Medical School, Massachusetts General Hospital , Boston, MA , USA 46 Departments of Neurosurgery and Tumor Biology, University Medical Center Hamburg-Eppendorf , Hamburg , Germany 47 PEPperPRINT GmbH , Heidelberg , Germany 48 Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg , Heidelberg , Germany 49 OM-050. IDENTIFICATION OF PROGNOSTIC SERUM-ANTIBODIES AGAINST GLIOBLASTOMA-ASSOCIATED ANTIGENS Andreas Mock 50 Department of Neurosurgery, Klinikum Grosshadern, Ludwig-Maximilians-University , Munich , Germany 51 Spanish National Cancer Research Centre , Madrid , Spain 52 Dana-Farber Cancer Institute , Boston, MA , USA 53 OM-056. HUMAN NON-GCIMP GLIOBLASTOMA SUBTYPES EVOLVE FROM A COMMON PRONEURAL-LIKE PRECURSOR GLIOMA Tatsuya Ozawa 54 Karolinska Institute, Center for Molecular Medicine , Stockholm , Sweden 55 Karolinska University Hospital, Department of Neurology , Stockholm , Sweden 56 OM-066. LOW LEVELS OF HUMAN CYTOMEGALOVIRUS INFECTION IN GLIOBLASTOMA MULTIFORME ASSOCIATES WITH PATIENT SURVIVAL; A PROSPECTIVE STUDY Giuseppe Stragliotto 57 OM-073. GENOMIC CHARACTERIZATION OF SPATIAL AND TEMPORAL HETEROGENEITY OF GLIOBLASTOMA MULTIFORME Hoon Kim 58 OM-072. LANDSCAPE OF CHROMOSOMAL COPY NUMBER ABERRATIONS (CNAS) IN GLIONEURONAL TUMORS (GNTS): RELATIVELY FREQUENT GAIN OF CHROMOSOME 5 AND/OR 7; CHROMOTHRIPSIS IN SUBSET OF CASES A Prabowo 59 Radboud University Nijmegen Medical Centre , Nijmegen , The Netherlands 60 Swammerdam Insitute for Life Sciences, Centre for Neuroscience, University of Amsterdam , Amsterdam , The Netherlands 61 Emory University , Atlanta, GA , USA 62 Henry Ford Health System , Detroit, MI , USA 63 The University of Texas MD Anderson Cancer Center , Houston, TX , USA 64 SEIN- Stichting Epilepsie Instellingen Nederland , Heemstede , The Netherlands 65 Dept of Clinical Neurophysiology, University Medical Center Utrecht , Utrecht , The Netherlands 66 Dept of Pathology,University Medical Center Utrecht , Utrecht , The Netherlands 67 The Broad Institute of Harvard and MIT , Cambridge, MA , USA 68 Case Western Reserve University School of Med (...truncated)